Literature DB >> 30578306

Induction of the BIM Short Splice Variant Sensitizes Proliferating NK Cells to IL-15 Withdrawal.

Benedikt Jacobs1,2, Aline Pfefferle3, Dennis Clement1,2, Axel Berg-Larsen1,2, Michelle L Saetersmoen1,2, Susanne Lorenz4,5, Merete Thune Wiiger1,2, Jodie P Goodridge1,2, Karl-Johan Malmberg6,2,3.   

Abstract

Adoptive transfer of allogeneic NK cells holds great promise for cancer immunotherapy. There is a variety of protocols to expand NK cells in vitro, most of which are based on stimulation with cytokines alone or in combination with feeder cells. Although IL-15 is essential for NK cell homeostasis in vivo, it is commonly used at supraphysiological levels to induce NK cell proliferation in vitro. As a result, adoptive transfer of such IL-15-addicted NK cells is associated with cellular stress because of sudden cytokine withdrawal. In this article, we describe a dose-dependent addiction to IL-15 during in vitro expansion of human NK cells, leading to caspase-3 activation and profound cell death upon IL-15 withdrawal. NK cell addiction to IL-15 was tightly linked to the BCL-2/BIM ratio, which rapidly dropped during IL-15 withdrawal. Furthermore, we observed a proliferation-dependent induction of BIM short, a highly proapoptotic splice variant of BIM in IL-15-activated NK cells. These findings shed new light on the molecular mechanisms involved in NK cell apoptosis following cytokine withdrawal and may guide future NK cell priming strategies in a cell therapy setting.
Copyright © 2019 by The American Association of Immunologists, Inc.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 30578306     DOI: 10.4049/jimmunol.1801146

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  4 in total

Review 1.  Deciphering Natural Killer Cell Homeostasis.

Authors:  Aline Pfefferle; Benedikt Jacobs; Alvaro Haroun-Izquierdo; Lise Kveberg; Ebba Sohlberg; Karl-Johan Malmberg
Journal:  Front Immunol       Date:  2020-05-12       Impact factor: 7.561

2.  Interleukin-15 enhanced the survival of human γδT cells by regulating the expression of Mcl-1 in neuroblastoma.

Authors:  Hui Wang; Xiaolin Wang; Wei Wang; Wenjia Chai; Wenqi Song; Hui Zhang; Wenjun Mou; Mengmiao Pei; Yan Su; Xiaoli Ma; Jingang Gui
Journal:  Cell Death Discov       Date:  2022-03-29

Review 3.  Overcoming tumor resistance mechanisms in CAR-NK cell therapy.

Authors:  Antonio Valeri; Almudena García-Ortiz; Eva Castellano; Laura Córdoba; Elena Maroto-Martín; Jessica Encinas; Alejandra Leivas; Paula Río; Joaquín Martínez-López
Journal:  Front Immunol       Date:  2022-08-03       Impact factor: 8.786

Review 4.  You Have Got a Fast CAR: Chimeric Antigen Receptor NK Cells in Cancer Therapy.

Authors:  Aline Pfefferle; Nicholas D Huntington
Journal:  Cancers (Basel)       Date:  2020-03-17       Impact factor: 6.639

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.